Tag: grant
-
Genome Institute to Fund Research on Rare Diseases, Medical Care
Funding announced by the National Human Genome Research Institute (NHGRI), part of National Institutes of Health, will support new research on rare inherited diseases, informatics tools, and use of genomic data in medical care delivery. The four-year, $416 million plan also continues funding for current initiatives on large-scale genomic sequencing production. NHGRI plans to award…
-
UC San Francisco, GE to Partner on Cord Blood Research
University of California at San Francisco and and GE Healthcare are collaborating on an R&D project to help overcome the lack of blood-forming stem cells available to patients suffering from several life-threatening diseases. The three-year, $841,000 project aims to make better use of umbilical cord blood gathered at the birth of a baby, which is…
-
Senate Passes SBIR/STTR Reauthorization in DoD Funding Bill
The U.S. Senate yesterday passed a reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR and STTR) programs through 2019. The reauthorization of the SBIR and STTR programs were included in the larger Department of Defense authorization for the current 2012 fiscal year that began on 1 October. The bill passed…
-
Research Project to Develop Salad Vegetable Safety Science
A new research initiative aims to provide U.S. growers and industry with the scientific basis to answer questions about the safety of salad vegetables. The research, led by University of Maryland food science professor Robert Buchanan, will conduct tests and collect data to develop safe and hygienic practices in farming, packing, transporting, and storing fresh…
-
Fox Foundation to Fund Parkinson’s Drug Candidate Studies
Civitas Therapeutics Inc., a pharmaceutical company in Chelsea, Massachusetts, received a grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support the company’s lead drug candidate CVT-301. The amount of the grant to fund clinical development of the drug was not disclosed. Parkinson’s disease occurs when the nerve cells in the brain…
-
Junior Faculty Entrepreneurship Fellowship Grants Open
The Ewing Marion Kauffman Foundation in Kansas City, Missouri has opened the next round of nominations for the Kauffman Junior Faculty Fellowship (KJFF) in Entrepreneurship Research. Each fellowship awards $40,000 to the fellow’s university to support the recipient’s research for two years. The foundation plans to award up to seven KJFF grants to junior faculty…
-
Personalized Health Informatics Technology in Development
A team of European and Israeli researchers is developing technology for real-time, personalized health monitoring that can minimize the number of follow-up visits patients need to make to health care providers. The EU has granted about €6 million ($US8.1 million) over four years to fund the project. The MOBIGUIDE project will involve researchers from five…
-
Scripps, Biotech to Partner on Feline Virus Research
CytoDyn Inc., a biotechnology company in Lutz, Florida, has agreed to support research by Spripps Research Institute scientist John Elder on the company’s treatment for feline immunodeficiency virus (FIV). Elder is a professor in Scripps’s Department of Immunology and Microbial Science in La Jolla, California. Under the agreement CytoDyn’s subsidiary, CytoDyn Veterinary Medicine LLC will…
-
Intel Corp. to Fund 3D Computer Processing Unit Development
Computer engineers at North Carolina State University in Raleigh are developing a three-dimensional central processing unit (CPU) that aims to increase energy efficiency by 15 percent. The project, funded by a $1.5 million grant from the Intel Corporation, is led by Paul Franzon, a professor of electrical and computer engineering at NC State. A 3D…
-
Geron Halts Embryonic Stem Cell Research, Clinical Trial
Geron Corporation, a biotechnology company in Menlo Park, California, says it has discontinued its development of therapies based on human embryonic stem cells to focus on cancer drugs. The immediate results of its decision are to end a clinical trial of its stem cell drug on patients with spinal cord injuries — the first clinical…